Ocular Therapeutix, Inc. Financial Ratios — OCUL Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-53.61	-63.14	-162.21	-193.41	- -	- -	-7.99	-115.16	-127.64	-95.21	-54.85
Return on Assets (%)	- -	-59.94	-58.86	-42.17	-48.26	-97.24	-93.37	-113.81	-91.39	-2.81	-40.11	-40.23	-54.51	-42.01
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	30	- -	88.21	81.77	76.52	76.24	76.63	45	88.03	89.88	91.18	90.96	91.17	87.35
EBITDA Margin (%)	-132,670	- -	-3,438.73	-2,139.6	-2,249.34	-3,135.62	-2,855.88	-1,970	-345.19	-173.74	-148.65	-135.86	-263.63	-511.43
Operating Margin (%)	-136,710	- -	-3,509.59	-2,182.69	-2,296.03	-3,220.12	-2,970.75	-2,029.86	-361.13	-179.3	-152.74	-140.96	-269.57	-519.75
Incremental Operating Margin (%)	- -	-7,680	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-140,930	- -	-3,710.88	-2,271.31	-2,369	-3,296.2	-3,013.97	-2,043.34	-894.31	-15.06	-137.95	-138.14	-303.67	-511.9
Profit Margin (%)	-140,930	- -	-3,710.88	-2,271.31	-2,369	-3,296.2	-3,013.97	-2,043.34	-894.31	-15.06	-137.95	-138.14	-303.67	-511.9
Net Income to Common Margin (%)	-141,280	- -	-3,712.31	-2,271.31	-2,369	-3,296.2	-3,013.97	-2,043.34	-894.31	-15.06	-137.95	-138.14	-303.67	-511.9
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.25	0.2	0.04	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-53.61	-63.14	-162.21	-193.41	- -	- -	-7.99	-115.16	-127.64	-95.21	-54.85

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	4	2	15	15	16	18	25	59	58	59	64	83	76	77
ST Debt	2	2	1	- -	2	6	- -	1	10	2	2	2	2	3
LT Debt	2	1	14	15	14	12	25	58	49	57	63	82	74	74
Total Debt/EBITDA	-0.31	-0.2	-0.56	-0.41	-0.37	-0.3	-0.44	-0.71	-0.97	-0.78	-0.84	-1.05	-0.45	-0.29
Net Debt/EBITDA	1.49	1.2	0.85	0.41	0.41	0.39	0.52	0.06	2.97	1.49	0.63	1.52	1.93	2.51
Total Debt/EBIT	-0.3	-0.19	-0.55	-0.4	-0.36	-0.29	-0.42	-0.69	-0.93	-0.76	-0.82	-1.01	-0.44	-0.29
Net Debt/EBIT	1.45	1.17	0.83	0.41	0.4	0.38	0.5	0.06	2.84	1.44	0.61	1.47	1.88	2.47
EBITDA to Interest Expense	-35.19	-28.34	-23.72	-21.72	-25.26	-31.87	-32.68	-13.65	-8.88	-11.34	-10.9	-7	-12.37	-22.45
EBITDA-CapEx/Interest Expense	-35.73	-29.22	-24.85	-22.75	-26.41	-36.23	-33.77	-14.02	-9	-11.51	-11.43	-7.54	-12.47	-23.46
EBIT to Interest Expense	-36.26	-29.26	-24.21	-22.16	-25.79	-32.73	-34	-14.06	-9.29	-11.7	-11.2	-7.27	-12.65	-22.82
Interest Expense	- -	- -	1	2	2	2	2	6	7	7	7	11	14	12
Common Equity/Total Assets	-444.67	-310.62	75.07	81.22	69.4	47.17	49.11	-4.61	29.06	42.95	23.7	36.15	68.86	80.97
Long-Term Debt/Equity (%)	- -	- -	23.02	17.05	27.1	47.7	69.1	- -	64.12	65.18	177.18	89.76	23.42	11.33
Long-Term Debt/Capital (%)	-5.31	-1.14	18.37	14.56	20.83	28.24	40.86	104.49	36.27	39.02	62.9	46.87	18.88	10.14
Long-Term Debt/Total Assets (%)	8.93	3.4	17.28	13.85	18.81	22.5	33.94	73.94	18.63	28	41.99	32.45	16.13	9.18
Total Debt/Equity (%)	-8.72	-4.13	25.33	17.05	30.08	68.9	69.1	-1,634.79	76.8	67.03	181.7	91.5	24.03	11.76
Total Debt/Capital (%)	-9.55	-4.31	20.21	14.56	23.12	40.79	40.86	106.52	43.44	40.13	64.5	47.78	19.38	10.53
Total Debt/Total Assets (%)	16.08	12.83	19.01	13.85	20.87	32.5	33.94	75.37	22.32	28.79	43.06	33.08	16.55	9.53
Net Debt to Equity	42.46	25.3	-38.38	-17.31	-33.25	-89.96	-81.6	141.18	-234.61	-128.1	-136.5	-132.65	-102.62	-101.74
Net Debt/Capital (%)	29.8	20.19	-62.29	-20.94	-49.81	-896.08	-443.48	-401.65	190.89	656.09	1,830.71	567.87	33,189.44	11,513.73
EBITDA	-13	-12	-27	-37	-42	-60	-57	-83	-60	-76	-77	-79	-168	-266
EBITDA-CapEx	-13	-13	-28	-39	-44	-69	-59	-86	-61	-77	-80	-85	-169	-278
Operating Income (Loss)	-14	-13	-27	-38	-43	-62	-59	-86	-63	-78	-79	-82	-172	-270

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	6.86	5.24	12.74	19.54	8.21	3.09	5.9	4.53	8.55	6.23	3.26	5.61	9.48	14.51
Current Ratio	6.98	5.39	12.97	19.89	8.42	3.23	6.14	5	9.23	7.26	4.13	6.66	10.66	15.39
Quick Ratio	6.88	5.32	12.79	19.57	8.24	3.11	5.92	4.74	9.01	7.04	3.94	6.36	10.26	15.11
CFO/Avg Current Liab	- -	-3.71	-4.45	-6	-4.97	-4.65	-4.36	-7.32	-2.77	-2.47	-2.06	-2.12	-3.53	-4.45
Common Equity/Total Assets	-444.67	-310.62	75.07	81.22	69.4	47.17	49.11	-4.61	29.06	42.95	23.7	36.15	68.86	80.97
Long-Term Debt/Equity (%)	- -	- -	23.02	17.05	27.1	47.7	69.1	- -	64.12	65.18	177.18	89.76	23.42	11.33
Long-Term Debt/Capital (%)	-5.31	-1.14	18.37	14.56	20.83	28.24	40.86	104.49	36.27	39.02	62.9	46.87	18.88	10.14
Long-Term Debt/Total Assets (%)	8.93	3.4	17.28	13.85	18.81	22.5	33.94	73.94	18.63	28	41.99	32.45	16.13	9.18
Total Debt/Equity (%)	-8.72	-4.13	25.33	17.05	30.08	68.9	69.1	-1,634.79	76.8	67.03	181.7	91.5	24.03	11.76
Total Debt/Capital (%)	-9.55	-4.31	20.21	14.56	23.12	40.79	40.86	106.52	43.44	40.13	64.5	47.78	19.38	10.53
Total Debt/Total Assets (%)	16.08	12.83	19.01	13.85	20.87	32.5	33.94	75.37	22.32	28.79	43.06	33.08	16.55	9.53
CFO/Total Liabilities	-17.5	-16.08	-105.12	-162.87	-148.28	-172.36	-132.44	-94.18	-28.83	-56.08	-52.32	-43.64	-94.45	-133.26
CFO/CapEx	-62	-32.67	-16.27	-18.98	-17.72	-6.12	-26.06	-34.66	-63.68	-54.9	-16.04	-11.54	-104.56	-17.06
Altman's Z-Score	-3.43	-5.75	13.79	5.06	1.34	-6.29	-4.9	-8.18	2.48	-1.06	-5.25	-1.87	2.89	8.27

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	2.58	6.7	8.52	8.08	9.32	3.08	2.35	2.61	2.43	2.46	2.18	1.65
Days Sales Outstanding	- -	- -	141.37	54.44	42.84	45.17	39.16	118.69	155.2	140	150.48	148.34	167.73	221.45
Inventory Turnover	- -	- -	1.37	2.39	3.59	3.89	2.74	3.97	1.93	3.6	2.82	2.47	2.11	1.99
Days Inventory Outstanding	- -	- -	266.73	152.75	101.76	93.85	133.05	91.92	188.81	101.52	129.6	147.87	173.38	183.33
Accounts Payable Turnover	- -	- -	0.24	0.2	0.21	0.16	0.17	0.98	0.78	1.22	1.08	1.18	1.49	1.7
Accounts Payable Turnover Days	- -	- -	1,516.22	1,866.63	1,761.43	2,227.2	2,130.04	371.5	468.16	299.09	336.81	309.33	245.73	214.18
Cash Conversion Cycle	- -	- -	-1,108.12	-1,659.44	-1,616.83	-2,088.18	-1,957.83	-160.89	-124.14	-57.56	-56.73	-13.11	95.38	190.6
Inventory to Cash Days	- -	- -	-125.36	-98.31	-58.91	-48.67	-93.89	26.77	-33.61	38.48	20.88	0.47	-5.65	38.11
Inventories	- -	- -	- -	- -	- -	- -	- -	1	1	1	2	2	3	4
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	2
Finished Goods	- -	- -	- -	- -	- -	- -	- -	1	1	- -	1	1	1	2
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	502	232	209	132	165	199	1,573	535	217	513	1,347	2,621
- Cash & Cash Equivalents	24	18	37	31	33	42	54	54	228	164	102	196	392	737
+ Preferred Equity and Hybrid Capital	66	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	2	15	15	16	18	25	59	58	59	64	83	76	77
Enterprise Value	46	-15	442	142	157	108	136	204	1,404	430	179	400	1,031	1,961
Total Capital	-43	-57	74	105	68	44	61	56	135	147	100	175	391	731
Total Debt/Capital (%)	-9.55	-4.31	20.21	14.56	23.12	40.79	40.86	106.52	43.44	40.13	64.5	47.78	19.38	10.53
Total Debt / EV	0.09	-0.16	0.03	0.11	0.1	0.17	0.18	0.29	0.04	0.14	0.36	0.21	0.07	0.04
EV/Sales	4,603.4	- -	572.28	81.21	83.17	56.4	68.33	48.2	80.65	9.87	3.47	6.85	16.18	37.75
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	251	218	208	128	152	179	1,258	573	232	382	1,352	2,273
Diluted Enterprise Value	46	-15	228	202	190	105	122	184	1,088	467	194	269	1,035	1,613
EV per Share	2.24	- -	20.71	5.74	6.27	3.66	3.27	4.05	18.47	5.6	2.32	3.48	6.53	9.08
TTM Sales	- -	- -	1	2	2	2	2	4	17	44	51	58	64	52
TTM EBITDA	-13	-12	-27	-37	-42	-60	-57	-83	-60	-76	-77	-79	-168	-266
TTM Operating Income	-14	-13	-27	-38	-43	-62	-59	-86	-63	-78	-79	-82	-172	-270
TTM Cash Flow to Firm	-12	-12	-19	-32	-32	-49	-47	-71	-47	-59	-53	-59	-121	-193
TTM Free Cash Flow to Firm	-12	-12	-18	-30	-30	-40	-46	-69	-46	-58	-49	-53	-120	-181

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-13.03	-6.81	-6.47	-3.04	-3.2	-2.37	-23.86	-8.9	-4.16	-5.95	-10.13	-11.79
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	46	-15	442	142	157	108	136	204	1,404	430	179	400	1,031	1,961
Low Price	- -	- -	11.9	6.74	4.04	3.3	3.55	2.35	3.78	6.02	2.57	2	3.76	5.79
EV/Sales	4,603.4	- -	572.28	81.21	83.17	56.4	68.33	48.2	80.65	9.87	3.47	6.85	16.18	37.75
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-5.93	-12.86	-4.35	-3.36	-3.86	-2.05	-3.4	-154.9	-4.78	-4.38	-6.41	-7.01
Price/Earnings High	- -	- -	-9	-25.84	-8.05	-5.36	-5.26	-2.91	-9.49	-276.05	-7.99	-7.87	-9.63	-11.58
Price/Earnings Low	- -	- -	-4.42	-3.94	-2.24	-1.5	-2.26	-1.23	-1.47	-70.18	-2.78	-1.97	-3.08	-4.08
Price/Book Value	- -	- -	8.55	2.59	4.03	5.05	4.61	-54.77	20.67	6.08	6.13	5.63	4.27	4.01
Price/Book Value Average	- -	- -	5.8	6.08	3.77	8.38	7.03	-54.31	8.71	11.59	9.64	5.59	3.92	3.29
Price/Book Value High	- -	- -	8.8	12.21	6.98	13.37	9.58	-76.96	24.27	20.65	16.1	10.04	5.89	5.43
Price/Book Value Low	- -	- -	4.33	1.86	1.94	3.74	4.11	-32.59	3.77	5.25	5.61	2.52	1.88	1.91
Price/Tangible Book Value	- -	- -	8.55	2.59	4.03	5.05	4.61	-54.77	20.67	6.08	6.13	5.63	4.27	4.01
Price/Tangible Book Value Average	- -	- -	5.8	6.08	3.77	8.38	7.03	-54.31	8.71	11.59	9.64	5.59	3.92	3.29
Price/Tangible Book Value High	- -	- -	8.8	12.21	6.98	13.37	9.58	-76.96	24.27	20.65	16.1	10.04	5.89	5.43
Price/Tangible Book Value Low	- -	- -	4.33	1.86	1.94	3.74	4.11	-32.59	3.77	5.25	5.61	2.52	1.88	1.91
Price/Sales	- -	- -	324.55	124.46	110.08	66.69	76.23	42.31	72.26	12.23	4.2	6.09	21.21	43.75
Price/Sales Average	- -	- -	220.18	292.2	103.07	110.67	116.42	41.95	30.43	23.32	6.6	6.05	19.45	35.88
Price/Sales High	- -	- -	334.07	586.95	190.69	176.69	158.53	59.44	84.83	41.56	11.02	10.87	29.26	59.25
Price/Sales Low	- -	- -	164.21	89.59	53.13	49.45	67.99	25.17	13.18	10.57	3.84	2.72	9.34	20.87
Price/Cash Flow	- -	- -	-12.22	-6.45	-6.11	-2.54	-3.08	-2.31	-23.48	-8.12	-3.62	-5.07	-10.04	-11.09
Price/Cash Flow Average	- -	- -	-8.29	-15.15	-5.72	-4.22	-4.71	-2.29	-9.89	-15.48	-5.7	-5.03	-9.2	-9.1
Price/Cash Flow High	- -	- -	-12.58	-30.44	-10.58	-6.73	-6.41	-3.24	-27.57	-27.6	-9.52	-9.05	-13.84	-15.02
Price/Cash Flow Low	- -	- -	-6.19	-4.65	-2.95	-1.88	-2.75	-1.37	-4.28	-7.02	-3.31	-2.27	-4.42	-5.29
Price/Free Cash Flow Average	- -	- -	-8.84	-16	-6.06	-5.04	-4.89	-2.35	-10.05	-16.96	-6.53	-5.91	-9.29	-9.67
Price/Free Cash Flow High	- -	- -	-13.41	-32.13	-11.22	-8.05	-6.66	-3.34	-28.01	-30.23	-10.91	-10.62	-13.98	-15.96
Price/Free Cash Flow Low	- -	- -	-6.59	-4.9	-3.13	-2.25	-2.86	-1.41	-4.35	-7.69	-3.8	-2.66	-4.46	-5.62
EV/Sales Average	4,603.4	- -	411.76	302.27	94.77	101.66	112.1	47.8	28.32	21.01	5.88	6.79	14.43	28.68
EV/Sales High	4,603.4	- -	639.84	616.12	183.12	169.6	157.97	67.25	96.37	39.33	10.33	13.73	24.2	55.62
EV/Sales Low	4,603.4	- -	299.66	86.53	44.41	38.66	59.35	29.14	6.74	8.2	3.11	2	4.34	11.36
EV/EBITDA Average	-3.47	1.2	-11.97	-14.13	-4.21	-3.24	-3.93	-2.43	-8.2	-12.09	-3.96	-5	-5.47	-5.61
EV/EBITDA High	-3.47	1.2	-18.61	-28.8	-8.14	-5.41	-5.53	-3.41	-27.92	-22.64	-6.95	-10.11	-9.18	-10.88
EV/EBITDA Low	-3.47	1.2	-8.71	-4.04	-1.97	-1.23	-2.08	-1.48	-1.95	-4.72	-2.1	-1.47	-1.65	-2.22
EV/EBIT Average	-3.37	1.17	-11.73	-13.85	-4.13	-3.16	-3.77	-2.35	-7.84	-11.72	-3.85	-4.82	-5.35	-5.52
EV/EBIT High	-3.37	1.17	-18.23	-28.23	-7.98	-5.27	-5.32	-3.31	-26.69	-21.94	-6.76	-9.74	-8.98	-10.7
EV/EBIT Low	-3.37	1.17	-8.54	-3.96	-1.93	-1.2	-2	-1.44	-1.87	-4.57	-2.04	-1.42	-1.61	-2.19
Last Price	- -	- -	23.52	9.37	8.37	4.45	3.98	3.95	20.7	6.97	2.81	4.46	8.54	12.14
High Price	- -	- -	24.21	44.19	14.5	11.79	8.28	5.55	24.3	23.68	7.38	7.96	11.78	16.44
Enterprise Value Average	46	-15	318	529	179	195	223	202	493	914	303	397	919	1,490
Enterprise Value High	46	-15	494	1,078	346	326	314	284	1,677	1,712	532	803	1,542	2,890
Enterprise Value Low	46	-15	231	151	84	74	118	123	117	357	160	117	277	590

Shares Outstanding	21	21	21	25	25	30	42	50	76	77	77	115	158	216
Diluted Weighted Avg Shares	3	3	11	23	25	29	38	45	61	82	83	86	158	187
Basic Weighted Avg Shares	3	3	11	23	25	29	38	45	61	76	77	80	158	187
Revenue per Share	- -	- -	0.07	0.08	0.08	0.07	0.05	0.09	0.29	0.57	0.67	0.73	0.4	0.28
EBITDA per Share	-4.49	-4.23	-2.49	-1.61	-1.71	-2.09	-1.49	-1.84	-0.99	-0.99	-1	-0.99	-1.06	-1.42
Operating Income per Share	-4.63	-4.37	-2.54	-1.64	-1.75	-2.15	-1.55	-1.9	-1.03	-1.02	-1.02	-1.03	-1.09	-1.44
Basic EPS, GAAP	-4.78	-4.52	-2.69	-1.71	-1.8	-2.2	-1.57	-1.91	-2.56	-0.09	-0.92	-1.01	-1.22	-1.42
Basic EPS from Cont Ops	-4.77	-4.51	-2.69	-1.71	-1.8	-2.2	-1.57	-1.91	-2.56	-0.09	-0.92	-1.01	-1.22	-1.42
Diluted EPS, GAAP	-4.78	-4.52	-2.69	-1.71	-1.8	-2.2	-1.57	-1.91	-2.56	-0.08	-0.86	-0.94	-1.22	-1.42
Diluted EPS from Cont Ops	-4.77	-4.51	-2.69	-1.71	-1.8	-2.2	-1.57	-1.91	-2.56	-0.08	-0.86	-0.94	-1.22	-1.42
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-4.26	-4.28	-1.92	-1.45	-1.37	-1.75	-1.29	-1.71	-0.88	-0.86	-0.78	-0.88	-0.85	-1.09
Free Cash Flow per Basic Share	-4.33	-4.41	-2.04	-1.53	-1.45	-2.04	-1.34	-1.76	-0.9	-0.87	-0.82	-0.96	-0.86	-1.16
Cash & Equivalents per Share	1.16	0.85	3.51	4.24	2.72	1.4	1.3	1.08	3	2.14	1.33	1.7	2.49	3.41
Book Value per Share	-5.47	-2.89	2.75	3.62	2.08	0.88	0.86	-0.07	1	1.15	0.46	0.79	2	3.03
Tangible Book Value per Share	-5.47	-2.89	2.75	3.62	2.08	0.88	0.86	-0.07	1	1.15	0.46	0.79	2	3.03

Ocular Therapeutix, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)